Organisation
- Acronym
- TUBITAK
- Role
- Partner
- Country
- TR
- Address
- Tunus Caddesi No: 80 06680 Kavakl?dere Ankara
- Website
- https://tubitak.gov.tr/en
Partner
TR
TR
TÜRKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU
TUBITAK
Programme phases
4
TRANSCAN-1
2011–2014
View phase
TRANSCAN-2
2015–2021
View phase
TRANSCAN-3
2021–2027
View phase
TRANSCAN-4
2026–2031
View phase
Funding participation
Joint calls funded by this organisation.
Funded projects
Projects linked to this funding organisation.
ACCELERATE
Functional precision medicine platform for the treatment of pancreatic cancer
JTC 2024
View project
DC2M-TAEC
Detection, Classification, Characterization and Treatment Monitoring of Tumors by Accessible Epigenetic Classification
JTC 2023
View project
EPILUNAR
Epigenomic Profiling of Liquid Biopsy and Immunotherapy Resistance in Lung Cancer
JTC 2023
View project
EpiNanSarc
Sarcoma subtyping and stratification using genome-wide epigenetic profiling
JTC 2023
View project
ioAVATAR
Immune oncology Drug Discovery & Decision - Advanced ex Vivo Approach To Accelerate Response prediction for combined therapies in ovarian cancer
JTC 2024
View project
iParaCyts
Understanding and therapeutically exploiting the immunosuppressive paracrine signalling in the tumour microenvironment of metastatic lesions
JTC 2021
View project
METRICs
Metabolism/Metagenomics-based strategies for sensitization to Radio- and Immuno- therapy Combinations.
JTC 2024
View project
PERIMMUNE
INTRAPERITONEAL IMMUNE MODULATION FOR COLORECTAL PERITONEAL METASTASES
JTC 2021
View project
PROMETOV
Proteogenomic and targeted metabolomic analysis of ovarian cancer heterogeneity and its contribution to recurrence and therapy resistance.
JTC 2014
View project
RISEBrain
Reverting immune suppression to elicit brain metastasis control
JTC 2021
View project
SCIE-PANC
Stromal Compartment and Immune Epigenome spatial networks to counter therapy evasion in PANcreatic Cancer
JTC 2023
View project
SmartCAR-T
SmartCAR-T - Reprogramming of the tumor microenvironment with modular engineered CAR-T cells to augment the efficacy of immunotherapy
JTC 2021
View project
UCIPredict
Circulating tumour microenvironment components as Urothelial Cancer Immunotherapy Response Predictors.
JTC 2021
View project